Dr. John Cush RheumNow
5 years 7 months ago
Dr. Anne Stevens lecturing at @RWCSmtg on the history of pediatric Rheumatology. Sir Eric Bywaters was the Father of meeting day pediatric Rheumatology @RWCSmtg https://t.co/iZtPfgoyxa
Dr. John Cush RheumNow
5 years 7 months ago
Dr George F Still, among the first to write about children with arthritis, pediatric Rheumatology, in 1898, with his description of 22 kids with arthritis. @RWCSmtg https://t.co/Y6DOzooFjZ
Dr. John Cush RheumNow
5 years 7 months ago
EXCEED study in #PsA shows lower responses in women (vs men) treated with either secukinumab or adalimumab. Question is, why? @RWCSmtg @JointMD https://t.co/LFBQi1jtiu
Dr. John Cush RheumNow
5 years 7 months ago
In #PsA does it matter if you're on background MTX when treated with ixekizumab or adalimumab? MTX does augment ADA responses but it's not needed with IXE @RWCSmtg @JointMD https://t.co/9GpKjLS4ao
Dr. John Cush RheumNow
5 years 7 months ago
No increased risk of cancer with TNFi use in PsA patients @RWCSmtg @JointMD https://t.co/7VSI1Fd1hw
Dr. John Cush RheumNow
5 years 7 months ago
Partial control of #PsA on MTX- Control study shows that adding adalimumab is superior to just escalating MTX @RWCSmtg @JointMD https://t.co/nDWzf4HYwp
Dr. John Cush RheumNow
5 years 7 months ago
Drs. Kavanaugh, Ruderman, Ogdie at @RWCSmtg on the multiple domains of psoriatic arthritis #PsA @JointMD https://t.co/3uS6JxdfIR
Dr. John Cush RheumNow
5 years 7 months ago
RWCS Highlights - Day 1 (@uptotate)
The 2021 Rheumatology Winter Clinical Symposium (RWCS) launched yesterday as a hybrid meeting. Led by exceptional teachers and researchers in rheumatology, this live and streaming conference had many highlights.
https://t.co/eKSsrXmLvu https://t.co/Gy9YEaK6Z1
Dr. John Cush RheumNow
5 years 7 months ago
ACR Promotes New COVID-19 Vaccine Clinical Guidance for Rheumatic Patients
The ACR has published a draft guidance on the use of COVID-19 vaccination in RMD patients, based on the efforts of the North American Task Force.
https://t.co/uSPfvJB8EC https://t.co/9bwBdtHw5e
Dr. John Cush RheumNow
5 years 7 months ago
QD Clinic - Fever by the Numbers Diagnosis of Periodic Fever by Fever Duration https://t.co/q3ZmJLrgOO
Dr. John Cush RheumNow
5 years 7 months ago
Defects in NLRC4 inflammasome can drive IL 18 production in systemic JIA. @RWCSmtg https://t.co/ffzODTXd52
NEJM has reported the results of a trial showing semaglutide once weekly plus lifestyle intervention was associated with sustained, weight loss in overweight or obese adults; such that nearly one-third lost over 20% of their body weight.
Dr. John Cush RheumNow
5 years 7 months ago
309 RA pts from the Preconception Counseling in Active RA (PreCARA) cohort were treated according to a modified T2T approach, 188 children were born. 47% of pts were on a TNFi during Preg; 75% were in LDAremission before PREG but 90% by 3rd trimester https://t.co/eLffxrH0UV
Dr. John Cush RheumNow
5 years 7 months ago
Preprint from UK trial shows tocilizumab efficacy in COVID-19. 2022 TCZ vs 2094 usual care pts (also on dexamethasone), in hospitalized pts on ventilators. 28 day mortality was 29% on TCZ Vs 33% with usual care - TCZ had 23% incr probability of discharge https://t.co/Curd6W20qK https://t.co/0TbhJYh5vM
The 2021 Rheumatology Winter Clinical Symposium launched yesterday as a hybrid meeting. As always, this conference lends itself to data for the practical clinician. Here are my pearls about new developments in RA, checkpoint inhibitors and IV IgG taken from several sessions presented on Day 1.
